Message boards index | Help | Search messages | Sign in


+ UKCAB + Public area + News, events, announcments + BMS-986001, a novel thymidine analog NRTIwas found to have comparable efficacy t

BMS-986001, a novel thymidine analog NRTIwas found to have comparable efficacy t

Print
Pages: 1

Elijah Amooti
Member
Posts: 158
BMS-986001, a novel thymidine analog NRTIwas found to have comparable efficacy t
Posted on: September 10 2014, 12:48 pm

Hi

BMS-986001, a novel thymidine analog NRTI (nucleoside reverse transcriptase inhibitor) being developed by Oncolys BioPharma, when combined with efavirenz (Sustiva, Stocrin) and lamivudine (3TC, Epivir), was found to have comparable efficacy to tenofovir (Viread) in treatment-naive patients living with HIV, according to phase-2b study results

DETAILS CLICK  BELOW

http://www.thebodypro.com/content/74948/new-hiv-drug-bms-986001-safe-and-effective-in-trea.html?ic=700102
Logged

Print
Pages: 1

+ UKCAB + Public area + News, events, announcments + BMS-986001, a novel thymidine analog NRTIwas found to have comparable efficacy t